Zobrazeno 1 - 10
of 21
pro vyhledávání: '"M. Ratna Sudha"'
Publikováno v:
International Journal of Dentistry, Vol 2020 (2020)
Background. Probiotic organisms are known to reduce caries causing microorganisms mutans streptococci and lactobacilli. Aim of the Study. To evaluate the effect of probiotic Bacillus coagulans Unique IS2 on mutans streptococci and lactobacilli levels
Externí odkaz:
https://doaj.org/article/0c01a86a8a0540639bc5b059e0c23f77
Publikováno v:
Beneficial Microbes. 10:149-154
Acute diarrhoea is one of the leading causes of mortality in infants and young children. Evidence suggests that probiotics can reduce diarrhoea duration. As the effects of probiotics are strain specific, the effect of Bacillus clausii UBBC-07, a safe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1b4d19fd470ac459dd812ef848a519d
https://doi.org/10.3920/bm2018.0094
https://doi.org/10.3920/bm2018.0094
Publikováno v:
Beneficial microbes. 10(8)
This clinical trial was carried out to assess the effects of multi-strain probiotic capsule (UB0316: Lactobacillus salivarius UBLS-22, Lactobacillus casei UBLC-42, Lactobacillus plantarum, UBLP-40, Lactobacillus acidophilus UBLA-34, Bifidobacterium b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c72a10a17cf56743425834932b22c28e
https://pubmed.ncbi.nlm.nih.gov/31965834
https://pubmed.ncbi.nlm.nih.gov/31965834
Publikováno v:
Beneficial Microbes. 9:563-572
The efficacy of the probiotic strain, Bacillus coagulans Unique IS2 in the treatment of Irritable Bowel Syndrome (IBS) was evaluated in children. A total of 141 children of either sex in the age group 4-12 years, diagnosed with IBS according to the R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f1ef8965a87e1fb0659a9e549528c95
https://doi.org/10.3920/bm2017.0129
https://doi.org/10.3920/bm2017.0129
Publikováno v:
Beneficial Microbes. 4:211-216
This study was conducted to evaluate the anti-diarrhoeal activity of Bacillus clausii strain UBBC 07 in patients suffering from acute diarrhoea. A total of 27 patients (average age of 35.44±8.08 years) with acute diarrhoea were included in a prospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::309c6569041167050994bd4f7efd13b4
https://doi.org/10.3920/bm2012.0034
https://doi.org/10.3920/bm2012.0034
Publikováno v:
Indian Journal of Microbiology. 52:396-399
Bacterial vaginosis (BV) is the most prevalent vaginal infection worldwide and is characterized by reduction of native lactobacilli. Antimicrobial therapy used to cure the disease is often found to be ineffective. We postulate that Bacillus coagulans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ec5ee908276e4ec5e1ff92e80bf81da
https://doi.org/10.1007/s12088-011-0233-z
https://doi.org/10.1007/s12088-011-0233-z
Publikováno v:
Beneficial microbes. 3(2)
This study was conducted to evaluate the efficacy and safety of Saccharomyces boulardii strain Unique 28 in patients suffering from acute diarrhoea. A total of 25 patients (average age 30.72±4.38 years) with symptoms of acute diarrhoea (≥3 loose m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a14f0d0ac8e5164fdb6c459179827cc
https://pubmed.ncbi.nlm.nih.gov/22476321
https://pubmed.ncbi.nlm.nih.gov/22476321
Autor:
A K Maurya, M. Ratna Sudha
Publikováno v:
Beneficial microbes. 3(2)
Bacterial vaginosis (BV) is a common condition affecting millions of women annually and is characterised by a reduction in native lactobacilli. Antimicrobial therapy used to cure the disease is often found to be ineffective. We postulate that the pot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::564aa8e70a0347e1518df39ee61b3bd4
https://pubmed.ncbi.nlm.nih.gov/22433661
https://pubmed.ncbi.nlm.nih.gov/22433661
Autor:
P. Sawant, M. Ratna Sudha
Publikováno v:
Beneficial microbes. 2(3)
The objective of this research was to study the efficacy and safety of capsule 'UB03' to treat patients with Irritable Bowel Syndrome (IBS). Thirty patients with Rome II IBS were assigned to receive capsule 'UB03' (10 billion lyophilised bacteria and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3f41794c82bcc91440cac5c2f8cbea9
https://pubmed.ncbi.nlm.nih.gov/21986362
https://pubmed.ncbi.nlm.nih.gov/21986362